Clinical Trial Update: 18F-DCFPyL PET-CT Scan and Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update involving 18F-DCFPyL PET-CT for prostate cancer (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Lida Jafari | Conditions: Prostate Cancer Adenocarcinoma | Phase 2, Phase 3 | Status: UNKNOWN